Release behavior and toxicity profiles towards leukemia (WEHI-3B) cell lines 6-mercaptopurine-PEG-coated magnetite nanoparticles delivery systems

Release behavior and toxicity profiles towards leukemia (WEHI-3B) cell lines 6-mercaptopurine-PEG-coated magnetite nanoparticles delivery systems

The coating of an active drug, 6-mercaptopurine, into the iron oxide nanoparticles-polyethylene glycol (FNPs-PEG) in order to form a new nanocomposite, FPEGMP-2, was accomplished using coprecipitation technique. The resulting nanosized with a narrow size distribution magnetic polymeric particles sho...

Full description

Bibliographic Details
Main Authors:	Dorniani, Dena, Kura, Aminu Umar, Hussein-Al-Ali, Samer Hasan, Hussein, Mohd Zobir, Fakurazi, Sharida, Shaari, Abdul Halim, Ahmad, Zalinah
Format:	Article
Published:	Hindawi Publishing Corporation 2014

Similar Items

Cytotoxic profiles of a nanodrug delivery based on 6-mercaptopurine-coated magnetite-peg nanoparticles towards leukemia (WEHI-3B) cell lines
by: Dorniani, Dena, et al.
Published: (2014)

Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery system
by: Dorniani, Dena, et al.
Published: (2013)

Controlled-release formulation of perindopril erbumine loaded PEG-coated magnetite nanoparticles for biomedical applications
by: Dorniani, Dena, et al.
Published: (2014)

In vitro sustained release study of gallic acid coated with magnetite-PEG and magnetite-PVA for drug delivery system
by: Dorniani, Dena, et al.
Published: (2014)

Sustained release of prindopril erbumine from its chitosan-coated magnetic nanoparticles for biomedical applications
by: Dorniani, Dena, et al.
Published: (2013)

Improved anticancer effect of magnetite nanocomposite formulation of gallic acid (Fe3O4-PEG-GA) against lung, breast and colon cancer cells
by: Rosman, Raihana, et al.
Published: (2018)

Improved Anticancer Effect of Magnetite Nanocomposite Formulation of GALLIC Acid (Fe3O4-PEG-GA) Against Lung, Breast and Colon Cancer Cells
by: Raihana Rosman, et al.
Published: (2018-02-01)

Arginine–chitosan- and arginine–polyethylene glycol-conjugated superparamagnetic nanoparticles: preparation, cytotoxicity and controlled-release
by: Hussein Al-Ali, Samer Hasan, et al.
Published: (2014)

Development of a controlled-release anti-parkinsonian nanodelivery system using levodopa as the active agent.
by: Kura, Aminu Umar, et al.
Published: (2013)

Preparation of Tween 80-Zn/Al-levodopa-layered double hydroxides nanocomposite for drug delivery system
by: Kura, Aminu Umar, et al.
Published: (2014)

Preparation of chitosan nanoparticles as a drug delivery system for perindopril erbumine
by: Hussein-Al-Ali, Samer Hasan, et al.
Published: (2018)

Layered double hydroxide nanocomposite for drug delivery systems; bio-distribution, toxicity and drug activity enhancement
by: Kura, Aminu Umar, et al.
Published: (2014)

Nanotechnology in drug delivery: the need for more cell culture based studies in screening
by: Kura, Aminu Umar, et al.
Published: (2014)

Synthesis, characterization, controlled release and cytotoxic effect of anthranilic acid-loaded chitosan and polyethylene glycol-magnetic nanoparticles on murine macrophage raw 264.7 cells
by: Al Ali, Samer Hasan Hussein, et al.
Published: (2014)

Toxicity and metabolism of layered double hydroxide intercalated with levodopa in a Parkinson's disease model
by: Kura, Aminu Umar, et al.
Published: (2014)

Antimicrobial and controlled release studies of a novel nystatin conjugated iron oxide nanocomposite
by: Hussein-Al-Ali, Samer Hasan, et al.
Published: (2014)

Graphene oxide as a nanocarrier for controlled release and targeted delivery of an anticancer active agent, chlorogenic acid
by: Barahuie, Farahnaz, et al.
Published: (2017)

Acute oral toxicity and biodistribution study of zinc aluminium-levodopa nanocomposite
by: Kura, Aminu Umar, et al.
Published: (2015)

Effect of protocatechuic acid-layered double hydroxide nanoparticles on diethylnitrosamine/phenobarbital-induced hepatocellular carcinoma in mice
by: Abd Gani, Shafinaz, et al.
Published: (2019)

Effect of protocatechuic acid-layered double hydroxide nanoparticles on diethylnitrosamine/phenobarbital-induced hepatocellular carcinoma in mice.
by: Shafinaz Abd Gani, et al.
Published: (2019-01-01)

Graphene oxide-gallic acid nanodelivery system for cancer therapy
by: Dorniani, Dena, et al.
Published: (2016)

The in vitro therapeutic activity of ellagic acid-alginate-silver nanopeprintss on breast cancer cells (MCF-7) and normal fibroblast cells (3T3)
by: Hussein-Al-Ali, Samer Hasan, et al.
Published: (2016)

The impact of magnesium–aluminum-layered double hydroxide-based polyvinyl alcohol coated on magnetite on the preparation of core-shell nanoparticles as a drug delivery agent
by: Ebadi, Mona, et al.
Published: (2019)

Sustained release formulation of an anti-tuberculosis drug based on para-amino salicylic acid-zinc layered hydroxide nanocomposite
by: Saifullah, Bullo, et al.
Published: (2013)

Synthesis and Cytotoxicity Study of Magnetite Nanoparticles Coated with Polyethylene Glycol and Sorafenib–Zinc/Aluminium Layered Double Hydroxide
by: Mona Ebadi, et al.
Published: (2020-11-01)

Development of anti-cancer and anti-hypertensive nanodelivery systems using magnetite iron oxide-polymeric nanoparticles
by: Dorniani, Dena
Published: (2015)

Toxicity evaluation of zinc aluminium levodopa nanocomposite via oral routes in repeated dose study
by: Kura, Aminu Umar, et al.
Published: (2014)

Preparation and controlled-release studies of a protocatechuic acid-magnesium/aluminum-layered double hydroxide nanocomposite.
by: Barahuie, Farahnaz, et al.
Published: (2013)

Graphene oxide as a nanocarrier for a theranostics delivery system of protocatechuic acid and gadolinium/gold nanoparticles
by: Usman, Muhammad Sani, et al.
Published: (2018)

Chlorogenic acid intercalated Gadolinium–Zinc/Aluminium layered double hydroxide and gold nanohybrid for MR imaging and drug delivery
by: Usman, Muhammad Sani, et al.
Published: (2020)

Graphene Oxide as a Nanocarrier for a Theranostics Delivery System of Protocatechuic Acid and Gadolinium/Gold Nanoparticles
by: Muhammad Sani Usman, et al.
Published: (2018-02-01)

Antileukemic effect of zerumbone-loaded nanostructured lipid carrier in WEHI-3B cell-induced murine leukemia model
by: Rahman, Heshu Sulaiman, et al.
Published: (2015)

Preparation of Fe3O4 magnetic nanoparticles coated with gallic acid for drug delivery
by: Dorniani D, et al.
Published: (2012-11-01)

Controlled release study of an anti-carcinogenic agent, gallate from the surface of magnetite nanoparticles.
by: Ghotbi, Mohammad Yeganeh, et al.
Published: (2012)

Thymoquinone inhibits murine leukemia WEHI-3 cells in vivo and in vitro
by: Salim, L.Z.A., et al.
Published: (2014)

Thymoquinone inhibits murine leukemia WEHI-3 cells in vivo and in vitro.
by: Landa Zeenelabdin Ali Salim, et al.
Published: (2014-01-01)

Graphene Oxide–PEG–Protocatechuic Acid Nanocomposite Formulation with Improved Anticancer Properties
by: Bullo Saifullah, et al.
Published: (2018-10-01)

Release behaviour and toxicity evaluation of levodopa from carboxylated single-walled carbon nanotubes
by: Tan, Julia M., et al.
Published: (2015)

Release behaviour and toxicity evaluation of levodopa from carboxylated single-walled carbon nanotubes
by: Julia M. Tan, et al.
Published: (2015-01-01)

Inhibits Murine Leukemia WEHI-3 Cells and Promotes Immune Response In Vivo
by: Hsin-Ling Yang PhD, et al.
Published: (2017-09-01)